本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Virpax Pharmaceuticals, Inc.

0.1665
-0.0115-6.46%
盤後0.1643-0.0022-1.32%19:58 EDT
成交量:145.57萬
成交額:24.30萬
市值:442.27萬
市盈率:-0.01
高:0.1764
開:0.1710
低:0.1608
收:0.1780
資料載入中...

公司資料

公司名字:
Virpax Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
2016
員工人數:
2
公司地址:
1055 Westlakes Drive,Suite 300,Berwyn,Pennsylvania,United States
郵編:
19312
電話:
傳真:
- -
簡介:
Virpax Pharmaceuticals, Inc.於2017年5月12日在特拉華州註冊成立。該公司是一家臨床前階段製藥公司,專註於開發跨越各種疼痛適應症的新型專有給藥系統,以增強依從性並優化每個在研產品候選者。該公司的藥物輸送系統和正在開發的藥物釋放技術專註於推進非阿片類藥物和非成癮性疼痛管理治療和中樞神經系統(“CNS”)疾病的治療,以提高患者的生活質量。

董事

名稱
職位
Eric Floyd
Independent Chairman of the Board
Gerald Bruce
Chief Executive Officer and Director
Barbara A. Ruskin
Independent Director
Jeffrey Gudin
Executive Vice President, Chief Medical Officer and Director
Jerrold Sendrow
Independent Director
Michael F. Dubin
Independent Director
Thani Jambulingam
Independent Director
Vanila M. Singh
Independent Director

股東

名稱
職位
Gerald Bruce
Chief Executive Officer and Director
Vinay Shah
Chief Financial Officer and Corporate Secretary
Jeffrey Gudin
Executive Vice President, Chief Medical Officer and Director
Sheila A. Mathias
Chief Scientific Officer